Related Experiment Video
Updated: May 9, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Camille N Kotton1, Deepali Kumar, Angela M Caliendo
1Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. ckotton@partners.org
Abstract:
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.
Insights
Cytomegalovirus (CMV) infection is common after solid-organ transplants, causing serious complications. Updated guidelines standardize CMV management, covering diagnostics, prevention, and treatment for better patient outcomes.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Virology
Background:
- Cytomegalovirus (CMV) is a frequent post-transplant complication, leading to significant morbidity and graft loss.
- Current CMV management strategies differ across transplant centers.
- Standardization is needed for optimal patient care and outcomes.
Framework:
- Revised consensus guidelines for CMV management were developed by an international expert panel.
- The guidelines incorporate evidence and expert opinion.
- Focus areas include diagnostics, immunology, prevention, treatment, drug resistance, and pediatric considerations.
Implementation:
- The guidelines aim to standardize CMV management protocols in solid-organ transplant recipients.
- Dissemination of these recommendations facilitates consistent clinical practice.
- Adoption of these guidelines can improve patient monitoring and intervention.
Implications:
- Standardized CMV management can reduce transplant-related morbidity and mortality.
- Improved prevention and treatment strategies enhance graft survival rates.
- Updated guidelines support evidence-based decision-making in post-transplant CMV care.
More Related Videos
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
Cytomegalovirus Disease
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Endocarditis III: Medical Management